Insights

Global Therapeutic Expertise Symbio Research's extensive international presence across the US, Europe, and Australia positions it as a versatile partner for clients seeking to conduct clinical trials in multiple regions, offering streamlined coordination and compliance support for global pharmaceutical companies.

Specialized Focus on Dermatology With a recent merger to form Symbio Proinnovera, the company has strengthened its dermatology segment, making it an attractive partner for clients developing dermatological therapies, particularly in areas like psoriasis and aesthetic treatments.

Integrated Manufacturing Capabilities Having dedicated in-house facilities for topical formulation development, research, and small-scale manufacturing provides a unique selling point for clients needing end-to-end support from trial to product manufacturing, reducing project timelines and outsourcing risks.

Market Engagement and Thought Leadership Participation in industry events like the Aesthetic Conference & Exhibition and publication of white papers demonstrate Symbio’s active engagement in market trends and a position as a thought leader, which attracts innovative pharmaceutical and device companies seeking expertise.

Stable Financial Profile With revenue ranging from 50 to 100 million dollars, Symbio presents a financially stable partner, capable of supporting long-term trial programs and expanding service offerings, which is reassuring for clients planning large-scale or ongoing research collaborations.

Symbio Tech Stack

Symbio uses 8 technology products and services including Facebook Pixel, WordPress, Twemoji, and more. Explore Symbio's tech stack below.

  • Facebook Pixel
    Analytics
  • WordPress
    Content Management System
  • Twemoji
    Font Scripts
  • Element UI
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • All in One SEO
    Search Engines
  • Nginx
    Web Servers

Symbio's Email Address Formats

Symbio uses at least 1 format(s):
Symbio Email FormatsExamplePercentage
FLast@symbioresearch.comJDoe@symbioresearch.com
50%
FLast@symbioresearch.comJDoe@symbioresearch.com
50%

Frequently Asked Questions

What is Symbio's phone number?

Minus sign iconPlus sign icon
You can contact Symbio's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Symbio's stock symbol?

Minus sign iconPlus sign icon
Symbio is a publicly traded company; the company's stock symbol is SYMBIOX.BO.

What is Symbio's official website and social media links?

Minus sign iconPlus sign icon
Symbio's official website is symbioresearch.com and has social profiles on LinkedIn.

How much revenue does Symbio generate?

Minus sign iconPlus sign icon
As of December 2025, Symbio's annual revenue is estimated to be $1.8M.

What is Symbio's NAICS code?

Minus sign iconPlus sign icon
Symbio's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Symbio have currently?

Minus sign iconPlus sign icon
As of December 2025, Symbio has approximately 102 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: A. M.Cfo: J. M.Chief Commercial Officer: S. S.. Explore Symbio's employee directory with LeadIQ.

What industry does Symbio belong to?

Minus sign iconPlus sign icon
Symbio operates in the Pharmaceutical Manufacturing industry.

What technology does Symbio use?

Minus sign iconPlus sign icon
Symbio's tech stack includes Facebook PixelWordPressTwemojiElement UIjQuery MigrateMicrosoftAll in One SEONginx.

What is Symbio's email format?

Minus sign iconPlus sign icon
Symbio's email format typically follows the pattern of FLast@symbioresearch.com. Find more Symbio email formats with LeadIQ.

When was Symbio founded?

Minus sign iconPlus sign icon
Symbio was founded in 2002.

Symbio

Pharmaceutical ManufacturingNew York, United States51-200 Employees

With main offices in New York, California, Germany, France and Australia, Symbio is a specialized global therapeutic clinical research organization (CRO) with proven expertise in dermatology, aesthetics, inflammation and gastroenterology across Phases I-IV, medical device and non-interventional studies.  As a client-focused global full-service CRO, Symbio manages all core services in-house and delivers excellent service providing experienced qualified personnel to strategically manage all aspects of your clinical trials. These services are further supported by a dedicated laboratory, manufacturing and packaging facility focused on topical formulation, research and development as well as small scale manufacturing and clinical packaging and labelling services for all dosage forms. 

Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio trials receive the special attention they deserve. We take great pride in the strong relationships we have established over the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites.

Section iconCompany Overview

Phone number
Stock Symbol
SYMBIOX.BO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $50M$100M

    Symbio's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Symbio's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.